Puigvert Foundation

Futó vizsgálatok

• Fut, nem toboroz

  A study to learn about how well BAY 3401016 works in adults with Alport syndrome

  2024-516471-33-00· 2. fázis· Forrás

• Toboroz

  STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

  NCT07280585· 3. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  NCT07206225· 1. fázis· Forrás

• Toboroz

  A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  NCT06774131· 3. fázis· Forrás

• Toboroz

  Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

  NCT06668493· 1/2. fázis· Forrás

• Toboroz

  ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  NCT06902558· 2. fázis· Forrás

• Toboroz

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· 3. fázis· Forrás

• Toboroz

  Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate

  NCT06649357· Forrás

• Fut, nem toboroz

  European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection

  NCT06935487· Forrás

• Toboroz

  European Registry of Next Generation Imaging in Advanced Prostate Cancer

  NCT06866782· Forrás

• Toboroz

  HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

  NCT05373264· 3. fázis· Forrás

• Fut, nem toboroz

  A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alterations.

  2023-507684-19-00· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

  NCT06211764· 3. fázis· Forrás

• Toboroz

  An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

  NCT05939414· 3. fázis· Forrás

• Toboroz

  Rescue of Nephrons With ALE.F02 (RENAL-F02)

  NCT06047171· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

  NCT05794906· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

  NCT05714202· 3. fázis· Forrás

• Fut, nem toboroz

  A phase II prospective, open-label, multi-centre, single arm study of sasanlimab plus sacituzumab govitecan in BCG (Bacillus Calmette-Guérin)- unresponsive non-muscle invasive bladder cancer (NMIBC) patients.

  2024-518486-10-00· 2. fázis· Forrás

• Toboroz

  Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

  NCT03994471· 3. fázis· Forrás

• Toboroz

  International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

  NCT05363657· Forrás

• Toboroz

  Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasive bladder cancer versus the standard immunotherapy.

  2024-520006-19-00· 4. fázis· Forrás

• Toboroz

  LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  NCT04752722· 1/2. fázis· Forrás

• Fut, nem toboroz

  Atrasentan in Patients With IgA Nephropathy

  NCT04573478· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

  NCT04165317· 3. fázis· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

  NCT03711032· 3. fázis· Forrás

• Még nem toboroz

  Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma

  NCT02969083· 2. fázis· Forrás

• Fut, nem toboroz

  Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

  NCT03528694· 3. fázis· Forrás

• Fut, nem toboroz

  Effectiveness of Localized Prostate Cancer Treatments

  NCT01492751· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Hólyagrák7 toboroz
• IgA-nefropátia2 toboroz
• Policisztás vesebetegség2 toboroz
• Prosztatarák2 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Krónikus vesebetegség1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Fut, nem toboroz

  Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  NCT07161037· 2. fázis· Forrás

• Lezárult

  A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

  NCT06331299· 3. fázis· Forrás

• Lezárult

  A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

  NCT04919512· 2. fázis· Forrás

• Lezárult

  Phase 2 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

  NCT05097989· 2. fázis· Forrás

• Leállították

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· 3. fázis· Forrás

• Lezárult

  Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

  NCT05065970· 2. fázis· Forrás

• Lezárult

  A study of enfortumab vedotin given in the bladder for treatment of patients with non-muscle invasive bladder cancer (NMIBC).

  2023-503388-40-00· 1. fázis· Forrás

• Lezárult

  Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

  NCT04736199· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

  NCT04658862· 3. fázis· Forrás

• Lezárult

  The Impact of Manual Versus Mechanical Intestinal Suturing on the Incidence of Postoperative Complications Following Cystectomy With Ileal Conduit

  NCT06928220· Forrás

• Lezárult

  A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

  NCT03762850· 3. fázis· Forrás

Vizsgálati helyszínek

• Fundacio Puigvert1 vizsgálat
• Fundaciòn Puigvert1 vizsgálat
• FUNDACION PUIGVERT - Nephrology Department1 vizsgálat
• Fundació Puigvert35 vizsgálat
• Fundacio Puigvert (Site 0864)0 vizsgálat
• Barcelona0 vizsgálat
• Puigvert Foundation1 vizsgálat
• Fundacio Puigvert0 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Hólyagrák37 munka · 18 vizsgálat